Parabolic Drugs (Delisted) financials and balance sheet

BSE: 533211Pharmaceuticals & Biotechnology

Last traded ₹5.50 on 25 Jan 2021

Delisted on 11 Aug 2021.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Parabolic Drugs annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹928 Cr, year to Mar 2012A loss in 8 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2020

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs−1.7
  3. Other expenses−4.7
  4. Operating profit−6.4
  5. Depreciation−22
  6. Other income0.0
  7. One-off items0.0
  8. Finance costs−0.7
  9. Profit before tax−29
  10. Tax0.0
  11. Net profit−29

What the company owns

  • Plant, investments and other assets₹320 Cr
  • Receivables₹27 Cr
  • Inventory₹1 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Other liabilities₹192 Cr
  • Borrowings₹156 Cr

Profit and loss

Standalone, ₹ crore, years to March.Parabolic Drugs quarterly results

₹ croreMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 25 AugMar 2020Filed 25 Aug
Revenue from operations635928769451233767873180
––83951931038212089336
Materials and goods bought4516967693692563299263200
Employee costs––221917118952
Other expenses––491323843191685
Operating profit before depreciation––−70−69−77−306−42−16−15−6
Operating margin––−9.1%−15.3%−33.2%−403.3%−53.4%−22.1%−81.6%–
Materials, % of revenue––100.0%81.9%109.8%432.8%117.9%87.5%110.6%–
Employee costs, % of revenue––2.8%4.1%7.3%14.1%10.9%12.2%29.5%–
Other expenses, % of revenue––6.3%29.2%16.1%56.4%24.6%22.4%41.5%–
Depreciation and amortisation––5568736753352222
Operating profit after depreciation––−125−137−150−373−95−51−37−28
Other income–––––––410
Finance costs416470839910810831
Profit before one-off items and tax6966−195−220−249−481−105−55−39−29
One-off items––––––––−20
Profit before tax6966−195−220−249−481−105−55−41−29
1615−55−6113043200
Net profit5351−140−132−379−485−108−57−41−29
Net margin8.3%5.5%−18.2%−29.2%−162.8%−639.2%−138.6%−77.9%−224.8%–
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2011 and Mar 2012: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 25 AugMar 2020Filed 25 Aug
−887−916
Share capital6262
Reserves−949−978
985156
393398
867867
Total assets372348
312290
6059
Net debt984156
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2011, Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 25 AugMar 2020Filed 25 Aug
Earnings per share₹9.43₹8.27−₹22.58−₹21.29––−₹17.46−₹9.21−₹6.57−₹4.63
Diluted earnings per share₹9.43₹8.27−₹22.58−₹21.29––−₹17.46−₹9.21−₹6.57−₹4.63
Book value per share––––––––−₹143.32−₹148.06
Market cap at the year end (₹ crore)2651803927––53–107

Ratios

Standalone, years to March.

RatioMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 25 AugMar 2020Filed 25 Aug
Revenue growth22.4%46.2%−17.2%−41.4%−48.3%−67.4%2.7%−6.9%−75.1%−100.0%
Net profit growth54.6%−3.1%––––––––
Earnings per share growth−47.4%−12.3%––––––––
Return on equity––––––––4.6%–
Return on capital employed––––––––−37.4%–
Receivable days––––––––562–
Inventory days––––––––12–
Payable days––––––––1,325–
Cash conversion cycle, days––––––––−751–
Working capital days––––––––−3,645–
Asset turnover––––––––0.050.00
Assets per rupee of net worth––––––––−0.42−0.40
Sales per rupee of plant––––––––0.060.00
Plant being built, % of plant in use––––––––2.2%2.4%
Interest cover is left blank for the years to Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018, Mar 2019 and Mar 2020: operating profit after depreciation is a loss, and a loss covers no interest bill. Debt to equity is left blank for the years to Mar 2019 and Mar 2020: net worth is below zero, so there is no shareholders' money to set the borrowings against. Return on capital employed is left blank for the year to Mar 2020: net worth and borrowings together come to nought or less, so there is no money employed to set the operating profit against. No balance sheet is on record for the years to Mar 2011, Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2020.

Return on assets, latest year
−7.9%
Measure10 years5 years3 years
Operating margin, average–−140.1%−51.8%
Net margin, average−141.9%−270.1%−151.4%
Asset turnover, average––0.02

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Altman Z-scorePublished threshold 1.81––––––––−4.92−5.36
Receivables growth less revenue growthOur threshold 0 percentage points–––––––––97.84
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––––––––100.00
Assets under construction, years of additionsOur threshold 2 years of additions–––––––––10.35
Effective tax ratePublished threshold 17.16 per cent23.0222.92––––––––
A threshold marked as ours has no published figure; it is the line we read the check against.